183 related articles for article (PubMed ID: 37703322)
1. Development of Potent and Selective Coactivator-Associated Arginine Methyltransferase 1 (CARM1) Degraders.
Xie H; Bacabac MS; Ma M; Kim EJ; Wang Y; Wu W; Li L; Xu W; Tang W
J Med Chem; 2023 Sep; 66(18):13028-13042. PubMed ID: 37703322
[TBL] [Abstract][Full Text] [Related]
2. Identification, Synthesis, and Biological Evaluations of Potent Inhibitors Targeting Type I Protein Arginine Methyltransferases.
Li X; Zhang L; Xu J; Liu C; Zhang X; Abdelmoneim AA; Zhang Q; Ke J; Zhang Y; Wang L; Yang F; Luo C; Jin J; Ye F
J Chem Inf Model; 2022 Feb; 62(3):692-702. PubMed ID: 35098713
[TBL] [Abstract][Full Text] [Related]
3. Structure-based discovery of potent CARM1 inhibitors for colorectal cancer therapy.
Liu C; Li Y; Liu Z; Cao C; Lin M; Chen X; Yuan M; Fan Y; Gu X; Wang L; Yang F; Ye F; Jin J
Eur J Med Chem; 2024 Apr; 269():116288. PubMed ID: 38460270
[TBL] [Abstract][Full Text] [Related]
4. Automethylation of CARM1 allows coupling of transcription and mRNA splicing.
Kuhn P; Chumanov R; Wang Y; Ge Y; Burgess RR; Xu W
Nucleic Acids Res; 2011 Apr; 39(7):2717-26. PubMed ID: 21138967
[TBL] [Abstract][Full Text] [Related]
5. Histone arginine methyltransferase CARM1 selective inhibitor TP-064 induces apoptosis in endometrial cancer.
Inoue F; Sone K; Toyohara Y; Tanimoto S; Takahashi Y; Kusakabe M; Kukita A; Honjoh H; Nishijima A; Taguchi A; Miyamoto Y; Tanikawa M; Iriyama T; Uchino MM; Tsuruga T; Wada-Hiraike O; Oda K; Osuga Y
Biochem Biophys Res Commun; 2022 Apr; 601():123-128. PubMed ID: 35245741
[TBL] [Abstract][Full Text] [Related]
6. Differential CARM1 expression in prostate and colorectal cancers.
Kim YR; Lee BK; Park RY; Nguyen NT; Bae JA; Kwon DD; Jung C
BMC Cancer; 2010 May; 10():197. PubMed ID: 20462455
[TBL] [Abstract][Full Text] [Related]
7. A hypermethylation strategy utilized by enhancer-bound CARM1 to promote estrogen receptor α-dependent transcriptional activation and breast carcinogenesis.
Peng BL; Li WJ; Ding JC; He YH; Ran T; Xie BL; Wang ZR; Shen HF; Xiao RQ; Gao WW; Ye TY; Gao X; Liu W
Theranostics; 2020; 10(8):3451-3473. PubMed ID: 32206101
[TBL] [Abstract][Full Text] [Related]
8. Unraveling the complexity of histone-arginine methyltransferase CARM1 in cancer: From underlying mechanisms to targeted therapeutics.
Jin W; Zhang J; Chen X; Yin S; Yu H; Gao F; Yao D
Biochim Biophys Acta Rev Cancer; 2023 Jul; 1878(4):188916. PubMed ID: 37196782
[TBL] [Abstract][Full Text] [Related]
9. Coactivator-associated arginine methyltransferase-1 enhances nuclear factor-kappaB-mediated gene transcription through methylation of histone H3 at arginine 17.
Miao F; Li S; Chavez V; Lanting L; Natarajan R
Mol Endocrinol; 2006 Jul; 20(7):1562-73. PubMed ID: 16497732
[TBL] [Abstract][Full Text] [Related]
10. Discovery of small molecule ligands for the von Hippel-Lindau (VHL) E3 ligase and their use as inhibitors and PROTAC degraders.
Diehl CJ; Ciulli A
Chem Soc Rev; 2022 Oct; 51(19):8216-8257. PubMed ID: 35983982
[TBL] [Abstract][Full Text] [Related]
11. CARM1 arginine methyltransferase as a therapeutic target for cancer.
Santos M; Hwang JW; Bedford MT
J Biol Chem; 2023 Sep; 299(9):105124. PubMed ID: 37536629
[TBL] [Abstract][Full Text] [Related]
12. Virtual Screening with a Structure-Based Pharmacophore Model to Identify Small-Molecule Inhibitors of CARM1.
Ran T; Li W; Peng B; Xie B; Lu T; Lu S; Liu W
J Chem Inf Model; 2019 Jan; 59(1):522-534. PubMed ID: 30607947
[TBL] [Abstract][Full Text] [Related]
13. Discovery of Highly Potent and Efficient PROTAC Degraders of Androgen Receptor (AR) by Employing Weak Binding Affinity VHL E3 Ligase Ligands.
Han X; Zhao L; Xiang W; Qin C; Miao B; Xu T; Wang M; Yang CY; Chinnaswamy K; Stuckey J; Wang S
J Med Chem; 2019 Dec; 62(24):11218-11231. PubMed ID: 31804827
[TBL] [Abstract][Full Text] [Related]
14. Two-Stage Strategy for Development of Proteolysis Targeting Chimeras and its Application for Estrogen Receptor Degraders.
Roberts BL; Ma ZX; Gao A; Leisten ED; Yin D; Xu W; Tang W
ACS Chem Biol; 2020 Jun; 15(6):1487-1496. PubMed ID: 32255606
[TBL] [Abstract][Full Text] [Related]
15. Transition state mimics are valuable mechanistic probes for structural studies with the arginine methyltransferase CARM1.
van Haren MJ; Marechal N; Troffer-Charlier N; Cianciulli A; Sbardella G; Cavarelli J; Martin NI
Proc Natl Acad Sci U S A; 2017 Apr; 114(14):3625-3630. PubMed ID: 28330993
[TBL] [Abstract][Full Text] [Related]
16. Coactivator-associated arginine methyltransferase 1 controls oligodendrocyte differentiation in the corpus callosum during early brain development.
Ishino Y; Shimizu S; Tohyama M; Miyata S
Dev Neurobiol; 2022 Apr; 82(3):245-260. PubMed ID: 35220691
[TBL] [Abstract][Full Text] [Related]
17. The coactivator-associated arginine methyltransferase is necessary for muscle differentiation: CARM1 coactivates myocyte enhancer factor-2.
Chen SL; Loffler KA; Chen D; Stallcup MR; Muscat GE
J Biol Chem; 2002 Feb; 277(6):4324-33. PubMed ID: 11713257
[TBL] [Abstract][Full Text] [Related]
18. CARM1 (PRMT4) Acts as a Transcriptional Coactivator during Retinoic Acid-Induced Embryonic Stem Cell Differentiation.
Quintero CM; Laursen KB; Mongan NP; Luo M; Gudas LJ
J Mol Biol; 2018 Oct; 430(21):4168-4182. PubMed ID: 30153436
[TBL] [Abstract][Full Text] [Related]
19. E3 Ligase Ligands for PROTACs: How They Were Found and How to Discover New Ones.
Ishida T; Ciulli A
SLAS Discov; 2021 Apr; 26(4):484-502. PubMed ID: 33143537
[TBL] [Abstract][Full Text] [Related]
20. CARM1/PRMT4: Making Its Mark beyond Its Function as a Transcriptional Coactivator.
Suresh S; Huard S; Dubois T
Trends Cell Biol; 2021 May; 31(5):402-417. PubMed ID: 33485722
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
